2025年4月10日 星期四
首页        期刊介绍        编委会        投稿指南        期刊订阅        广告合作        联系我们        English
河北医学  2021, Vol. 27 Issue (7): 1178-1181    DOI: 10.3969/j.issn.1006-6233.2021.07.026
  临床研究 本期目录 | 过刊浏览 | 高级检索 |
SRM-IV诊疗系统在上半规管良性阵发性位置性眩晕诊治中的应用价值
杨秋云, 蒙楠, 韦福依
广西壮族自治区百色市人民医院耳鼻喉科, 广西 百色 533000
Application Value of Srm-iv System in Diagnosis and Treatment of Superior Semicircular Canal Benign Paroxysmal Positional Vertigo
YANG Qiuyun, MENG Nan, WEI Fuyi
Guangxi Baise People's Hospital, Guangxi Baise 533000, China
全文: PDF (1257 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的: 观察SRM-IV诊疗系统在上半规管良性阵发性位置性眩晕(AC-BPPV)诊治中的应用价值。方法: 前瞻性选取2018年2月至2021年2月期间百色市人民医院收治的110例AC-BPPV患者为研究对象,采用简单随机抽样法随机分为试验组(n=55例)与对照组(n=55例)。试验组对患者采用SRM-IV诊疗系统治疗,对照组给予患者常规手法复位治疗,两组均治疗1周。比较两组患者治疗1周后的治疗总有效率、治愈时间、主客观症状以及生活质量改善情况、并发症发生情况及复发率。结果: 试验组的治疗总有效率(96.36%)明显高于对照组(81.82%),差异有统计学意义(χ2=11.652,P<0.05);试验组的治愈时间(6.13±0.66)d明显短于对照组(6.99±0.74)d,差异有统计学意义(t=5.443,P<0.05);试验组主客观症状相关评分(UCLA-DQ、MSQ)治疗前后差值(2.46±0.14)分、(63.10±6.59)分,明显高于对照组的(1.58±0.28)分、(49.22±5.41)分;生活质量(DHI)评分治疗前后差值(36.12±2.33)分,显著高于对照组的(22.50±2.10)分;试验组并发症发生率(3.64%)明显低于对照组的18.18%,差异有统计学意义(P<0.05);试验组患者的复发率(3.64%)与对照组(5.45%)相比,差异无统计学意义(P>0.05)。结论: SRM-IV诊疗系统在上半规管良性阵发性位置性眩晕诊治中发挥积极作用,治疗效果显著且并发症少,安全可靠,同时显著改善患者主客观症状与生活质量,适于临床实践与应用。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
杨秋云
蒙楠
韦福依
关键词 上半规管良性阵发性位置性眩晕SRM-IV诊疗系统主客观症状生活质量并发症    
AbstractObjective: To observe the application value of SRM-IV system in the induction test of benign paroxysmal positional vertigo of superior semicircular canal (AC-BPPV). Methods: 110 patients with ac-bppv admitted to Baise people's Hospital from February 2018 to February 2021 were prospectively selected and randomly divided into experimental group (n = 55) and control group (n = 55) by simple random sampling method. The patients in the experimental group were treated with srm-iv diagnosis and treatment system, while the patients in the control group were treated with conventional manipulative reduction. Both groups were treated for 1 week. The total effective rate, cure time, subjective and objective symptoms, improvement of quality of life, occurrence of complications and recurrence rate of the two groups were compared after one week of treatment. Results: The total effective rate of the experimental group (96.36%) was significantly higher than that of the control group (81.82%), the difference was statistically significant( χ 2=11.652,P<0.05). The cure time of the experimental group [(6. 13 1 ± 66) D] was significantly shorter than that in the control group [(6. 99 0 ± 74) D], the difference was statistically significant (t = 5. 443, P< 0. 05). The difference of subjective and objective symptom related scores (UCLA-DQ, MSQ) before and after treatment in the experimental group [(2.46 0.05)] ± 14)] (63. 10 0 ± 59), which was significantly higher than that of the control group [(1. 58 6 ± 28) (49. 22 0 ± 41)]. The difference of quality of life (DHI) score before and after treatment [(36.12 1 ± 33), which was significantly higher than that of the control group [(22. 50 2 ± 10)]. The incidence of complications in the experimental group (3.64%) was significantly lower than that in the control group (18.18%), the difference was statistically significant (P<0.05). There was no significant difference in the recurrence rate between the experimental group (3.64%) and the control group (5.45%) (P>0.05). Conclusion: The SRM-IV diagnosis and treatment system plays an active role in the diagnosis and treatment of benign paroxysmal positional vertigo in the upper semicircular canal. The treatment effect is significant with few complications, safe and reliable, and at the same time, it significantly improves the subjective and objective symptoms and quality of life of patients. It is suitable for clinical practice and application.
Key wordsSuperior semicircular canal benign paroxysmal positional vertigo    SRM-IV diagnosis and treatment system    Subjective and objective symptoms    Quality of life    Complications
    
基金资助:广西省卫健委科研课题,(编号:Z20201146)
引用本文:   
杨秋云, 蒙楠, 韦福依. SRM-IV诊疗系统在上半规管良性阵发性位置性眩晕诊治中的应用价值[J]. 河北医学, 2021, 27(7): 1178-1181.
YANG Qiuyun, MENG Nan, WEI Fuyi. Application Value of Srm-iv System in Diagnosis and Treatment of Superior Semicircular Canal Benign Paroxysmal Positional Vertigo. HeBei Med, 2021, 27(7): 1178-1181.
链接本文:  
http://www.hbyxzzs.cn/CN/10.3969/j.issn.1006-6233.2021.07.026     或     http://www.hbyxzzs.cn/CN/Y2021/V27/I7/1178
冀ICP备2025106803号    冀公网安备13080202000786号
版权所有 © 2016 《河北医学》杂志社
本系统由北京玛格泰克科技发展有限公司设计开发